- Home
- XLO vs CCM Comparison
XLO vs CCM Comparison
Compare XLO & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XLO
- CCM
- Stock Information
- Founded
- XLO 2016
- CCM 1997
- Country
- XLO United States
- CCM China
- Employees
- XLO N/A
- CCM N/A
- Industry
- XLO Biotechnology: Pharmaceutical Preparations
- CCM Medical/Nursing Services
- Sector
- XLO Health Care
- CCM Health Care
- Exchange
- XLO Nasdaq
- CCM Nasdaq
- Market Cap
- XLO 35.7M
- CCM 33.3M
- IPO Year
- XLO 2021
- CCM 2009
- Fundamental
- Price
- XLO $0.75
- CCM $5.65
- Analyst Decision
- XLO Buy
- CCM
- Analyst Count
- XLO 2
- CCM 0
- Target Price
- XLO $3.00
- CCM N/A
- AVG Volume (30 Days)
- XLO 946.5K
- CCM 1.5K
- Earning Date
- XLO 11-06-2025
- CCM 09-22-2025
- Dividend Yield
- XLO N/A
- CCM N/A
- EPS Growth
- XLO N/A
- CCM N/A
- EPS
- XLO N/A
- CCM N/A
- Revenue
- XLO $15,001,000.00
- CCM $52,603,198.00
- Revenue This Year
- XLO $982.12
- CCM N/A
- Revenue Next Year
- XLO N/A
- CCM N/A
- P/E Ratio
- XLO N/A
- CCM N/A
- Revenue Growth
- XLO 536.45
- CCM N/A
- 52 Week Low
- XLO $0.62
- CCM $3.80
- 52 Week High
- XLO $1.70
- CCM $10.77
- Technical
- Relative Strength Index (RSI)
- XLO 60.31
- CCM 54.39
- Support Level
- XLO $0.71
- CCM $5.46
- Resistance Level
- XLO $0.78
- CCM $5.75
- Average True Range (ATR)
- XLO 0.04
- CCM 0.12
- MACD
- XLO 0.01
- CCM 0.03
- Stochastic Oscillator
- XLO 64.03
- CCM 61.80
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.